"THC Global Group Ltd's (ASX:THC) first Canndeo branded medicinal cannabis medicines produced in Australia will be available for prescription from May 20, 2020.
The company will supply its medicines directly to pharmacies, clinics and hospitals, meeting the Australian Government’s legislated requirements for supply of medicinal cannabis, and placing it in a unique position to support new patients under the legal medicinal cannabis access schemes."
As MGC have a supply agreement with THC Global (re: THC's Canndeo brand), I feel confident that orders would have been made to MGC from THC
Looking forward to hearing more from this Agreement.
MXC Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
